<DOC>
	<DOCNO>NCT00003746</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know give cladribine day effective give cladribine week patient hairy cell leukemia . PURPOSE : Randomized phase III trial compare effectiveness cladribine give day cladribine give week treat patient hairy cell leukemia .</brief_summary>
	<brief_title>Daily Weekly Cladribine Treating Patients With Hairy Cell Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Compare acute hematotoxicity infection rate daily weekly administration cladribine patient hairy cell leukemia . OUTLINE : This randomize , multicenter study . Patients randomize one two treatment arm . - Arm I : Patients receive daily subcutaneous bolus injection cladribine ( 2-CDA ) 5 day ( standard dose ) . - Arm II : Patients receive weekly subcutaneous bolus injection 2-CDA 5 week . Patients show complete partial remission evaluation day 71 first treatment course receive treatment relapse disease progression evident . Patients show minor response day 71 first treatment course receive subsequent course standard dose 2-CDA . Patients follow every 3 month 2 year , every 6 month thereafter . PROJECTED ACCRUAL : A total 120 patient accrue study within 4 year .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Hairy Cell</mesh_term>
	<mesh_term>Cladribine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm classic form prolymphocytic variant hairy cell leukemia ( HCL ) Newly diagnose HCL progressive disease prior treatment PATIENT CHARACTERISTICS : Age : 18 Performance status : NCI 02 Life expectancy : At least 3 month Hematopoietic : Not specify Hepatic : Bilirubin great 2.0 mg/dL Renal : Creatinine great 2.3 mg/dL Other : HIV negative Not pregnant No prior concurrent malignancy except carcinoma situ cervix basal squamous cell carcinoma skin PRIOR CONCURRENT THERAPY : At least 4 week since prior therapy recover Biologic therapy : Not specify Chemotherapy : No concurrent cytoreductive therapy No prior cladribine Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>untreated hairy cell leukemia</keyword>
	<keyword>progressive hairy cell leukemia , initial treatment</keyword>
	<keyword>prolymphocytic leukemia</keyword>
</DOC>